Hostname: page-component-848d4c4894-cjp7w Total loading time: 0 Render date: 2024-06-26T19:45:08.940Z Has data issue: false hasContentIssue false
  • English
  • Français

Genetic dilated cardiomyopathy with inflammation in an infant that responded to immunosuppressive therapy evaluated using cardiovascular magnetic resonance

Published online by Cambridge University Press:  12 April 2024

Hiromitsu Shirozu Open the ORCID record for Hiromitsu Shirozu [Opens in a new window] ,
Yuichi Ishikawa Open the ORCID record for Yuichi Ishikawa [Opens in a new window]  and
Nobuhiko Kan
Hiromitsu Shirozu*
Affiliation:
Department of Pediatric Cardiology, Fukuoka Children’s Hospital, Fukuoka, Japan
Yuichi Ishikawa
Affiliation:
Department of Pediatric Cardiology, Fukuoka Children’s Hospital, Fukuoka, Japan
Nobuhiko Kan
Affiliation:
Department of Pediatric Cardiology, Fukuoka Children’s Hospital, Fukuoka, Japan
*
Corresponding author: Hiromitsu Shirozu; Email: piro_uzz_1308@yahoo.co.jp
Get access Rights & Permissions [Opens in a new window]

Abstract

Cardiovascular magnetic resonance T1 and T2 mapping reflects inflammation, fibrosis, and myocardial oedema. However, its application in infants remains uncertain. Herein, we report a three-month-old boy with dilated cardiomyopathy successfully treated with steroids. Cardiovascular magnetic resonance was useful for diagnosis based on the elevated native T1, T2, and extracellular volume and evaluation of response to immunosuppressive therapy in infantile inflammatory dilated cardiomyopathy.

Keywords

dilated cardiomyopathycardiovascular magnetic resonanceT1T2 mapping
Type
Brief Report
Information
Cardiology in the Young , First View , pp. 1 - 3
Check for updates
Copyright
© The Author(s), 2024. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bozkurt, B, Colvin, M, Cook, J, et al. Current diagnostic and treatment strategies for specific dilated cardiomyopathies: a scientific statement from the American Heart Association. Circulation 2016; 134: e579–e646.CrossRefGoogle ScholarPubMed
Ferreira, VM, Schulz-Menger, J, Holmvang, G, et al. Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations. J Am Coll Cardiol 2018; 72: 3158–3176.CrossRefGoogle ScholarPubMed
Merken, J, Hazebroek, M, Van Paassen, P, et al. Immunosuppressive therapy improves both short- and long-term prognosis in patients with virus-negative nonfulminant inflammatory cardiomyopathy. Circ Heart Fail 2018; 11: e004228.CrossRefGoogle Scholar
Camargo, PR, Snitcowsky, R, da Luz, PL, et al. Favorable effects of immunosuppressive therapy in children with dilated cardiomyopathy and active myocarditis. Pediatr Cardiol 1995; 16: 61–68.CrossRefGoogle ScholarPubMed
Popa, MA, Klingel, K, Hadamitzky, M, et al. An unusual case of severe myocarditis in a genetic cardiomyopathy: a case report. Eur Heart J Case Rep 2020; 4: 1–7.CrossRefGoogle Scholar
dem Siepen, FAus, Buss, SJ, Messroghli, D, et al. T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy. Eur Heart J Cardiovasc Imaging 2015; 16: 210–216.CrossRefGoogle Scholar
Al-Wakeel-Marquard, N, Seidel, F, Herbst, C, et al. Diffuse myocardial fibrosis by T1 mapping is associated with heart failure in pediatric primary dilated cardiomyopathy. Int J Cardiol 2021; 333: 219–225.CrossRefGoogle ScholarPubMed
Ishikawa, Y, Urabe, H, Yamada, Y, et al. Normal ventricular and regional blood flow volumes and native T1 values in healthy Japanese children obtained from comprehensive cardiovascular magnetic resonance imaging. Int Heart J 2023; 64: 663–671.CrossRefGoogle ScholarPubMed